Home / TATVA.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does TATVA.NS make money? Does TATVA.NS have pricing power? What's the Earnings Whisper? Will TATVA.NS profit more as the business scales? What is TATVA.NS's management track record? Is TATVA.NS's current price justified?

Tatva Chintan Pharma Chem Limited

₹1944 +$619.30 (+46.75%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹1940.7

Day Range

₹1900₹1973.4

Year Range

₹1044.1₹2008.7

Market Cap

45.47B

AVG Volume

130.25K

Trailing/Forward PE

88.48/41.06

PEG ratio

1.45

Dividend Yield

0.10%

Next Earnings Date

2026-10-19

Primary Exchange

National Stock Exchange of India

Revenue (INR) · A

TATVA.NS Revenue (INR) by year
Period	Revenue (INR)
2026	5.06B
2025	3.83B
2024	3.94B
2023	4.24B
2022	4.34B
2021	3B

Net Income (INR) · A

TATVA.NS Net Income (INR) by year
Period	Net Income (INR)
2026	420.54M
2025	57.13M
2024	303.54M
2023	454.91M
2022	958.75M
2021	522.6M

Operating Income (INR) · A

TATVA.NS Operating Income (INR) by year
Period	Operating Income (INR)
2026	563.11M
2025	719.81M
2024	1.19B
2023	1.42B
2022	1.96B
2021	1.22B

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (INR) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Tatva Chintan Pharma Chem Limited

Video analysis: TATVA.NS

News: TATVA.NS

Similar companies